Ping Huang

443 total citations
26 papers, 324 citations indexed

About

Ping Huang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ping Huang has authored 26 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Ping Huang's work include Kawasaki Disease and Coronary Complications (21 papers), Coronary Artery Anomalies (15 papers) and Mechanical Circulatory Support Devices (5 papers). Ping Huang is often cited by papers focused on Kawasaki Disease and Coronary Complications (21 papers), Coronary Artery Anomalies (15 papers) and Mechanical Circulatory Support Devices (5 papers). Ping Huang collaborates with scholars based in China, Brazil and United States. Ping Huang's co-authors include Li Zhang, Yufen Xu, Xiaoqiong Gu, Zhiping Zheng, Luqian Zhao, Yanfei Wang, Di Che, Lei Pi, Wei Li and Hong-Ling Jia and has published in prestigious journals such as Circulation Research, American Heart Journal and Oncotarget.

In The Last Decade

Ping Huang

25 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Huang China 11 187 148 114 64 55 26 324
Shoichiro Otsuki Japan 8 49 0.3× 135 0.9× 97 0.9× 73 1.1× 38 0.7× 16 287
Ayesha Noorani United Kingdom 9 169 0.9× 258 1.7× 98 0.9× 144 2.3× 80 1.5× 16 449
Noriaki Kasayuki Japan 9 109 0.6× 59 0.4× 103 0.9× 159 2.5× 35 0.6× 28 337
Limin Xia China 9 187 1.0× 56 0.4× 76 0.7× 84 1.3× 30 0.5× 21 346
Tri Minh Le United States 10 250 1.3× 288 1.9× 57 0.5× 108 1.7× 28 0.5× 24 524
Maica Galán Spain 12 137 0.7× 208 1.4× 67 0.6× 20 0.3× 63 1.1× 29 395
Hadas Shiran United States 6 83 0.4× 243 1.6× 119 1.0× 198 3.1× 44 0.8× 11 416
Ye Lin China 8 77 0.4× 97 0.7× 127 1.1× 42 0.7× 33 0.6× 21 351
Vincent P.W. Scholtes Netherlands 10 99 0.5× 109 0.7× 38 0.3× 58 0.9× 58 1.1× 19 264
Miki N. Hew Netherlands 7 50 0.3× 233 1.6× 139 1.2× 38 0.6× 25 0.5× 11 285

Countries citing papers authored by Ping Huang

Since Specialization
Citations

This map shows the geographic impact of Ping Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Huang more than expected).

Fields of papers citing papers by Ping Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Huang. The network helps show where Ping Huang may publish in the future.

Co-authorship network of co-authors of Ping Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Huang. A scholar is included among the top collaborators of Ping Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Huang. Ping Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Li, Wei, et al.. (2022). Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease. International Journal of Clinical Practice. 2022(1). 2726686–2726686. 6 indexed citations
4.
Li, Wei, et al.. (2021). A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?. Cardiovascular Therapeutics. 2021. 1–7. 9 indexed citations
6.
Jiang, Zhiyong, Wei Li, Lei Pi, et al.. (2021). Integrin α2 gene polymorphism is a risk factor of coronary artery lesions in Chinese children with Kawasaki disease. Pediatric Rheumatology. 19(1). 12–12. 1 indexed citations
7.
Wang, Yanfei, Yufen Xu, Ping Huang, et al.. (2021). Homozygous of MRP4 Gene rs1751034 C Allele Is Related to Increased Risk of Intravenous Immunoglobulin Resistance in Kawasaki Disease. Frontiers in Genetics. 12. 510350–510350. 5 indexed citations
8.
Li, Wei, Lei Pi, Yunfeng Liu, et al.. (2021). Impact of Platelet Glycoprotein Ia/IIa C807T Gene Polymorphisms on Coronary Artery Aneurysms of KD Patients. Cardiology Research and Practice. 2021. 1–6. 4 indexed citations
9.
Zhang, Yuan, Yanfei Wang, Li Zhang, et al.. (2020). Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis. Circulation Research. 127(7). 855–873. 51 indexed citations
10.
Xu, Yufen, Yanfei Wang, Wei Li, et al.. (2020). Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients. Cardiovascular Therapeutics. 2020. 1–6. 9 indexed citations
11.
Wang, Yanfei, Xin‐Lei Lian, Jiayong Zhong, et al.. (2019). Serum exosomal microRNA let‐7i‐3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm. IUBMB Life. 71(7). 891–900. 22 indexed citations
12.
Wang, Yanfei, Zhaoliang Lu, Yaqian Tan, et al.. (2019). The miRNA-608 rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population. Bioscience Reports. 39(5). 5 indexed citations
13.
Huang, Ping, Lei Pi, Yufen Xu, et al.. (2019). The IL-1B Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease. Journal of Immunology Research. 2019. 1–7. 29 indexed citations
14.
Zhang, Li, Ping Huang, Xiaoqiong Gu, et al.. (2018). Weight and the vitamin K expoxide reductase 1 genotype primarily contribute to the warfarin dosing in pediatric patients with Kawasaki disease. Thrombosis Research. 167. 32–36. 1 indexed citations
15.
Che, Di, Jiawen Li, Lei Pi, et al.. (2018). The rs1625579 T&gt;G polymorphism in the <em>miRNA-137</em> gene confers a risk of early-onset Kawasaki disease in a southern Chinese population. Infection and Drug Resistance. Volume 11. 1055–1060. 11 indexed citations
16.
Xu, Yufen, et al.. (2018). Proteomics study of serum exosomes in Kawasaki disease patients with coronary artery aneurysms. Cardiology Journal. 26(5). 584–593. 19 indexed citations
17.
Che, Di, et al.. (2018). TBXA2R rs4523 G allele is associated with decreased susceptibility to Kawasaki disease. Cytokine. 111. 216–221. 10 indexed citations
18.
Lu, Zhaoliang, Yufen Xu, Yaqian Tan, et al.. (2018). P2RY12:rs7637803 TT variant genotype increases coronary artery aneurysm risk in Kawasaki disease in a southern Chinese population. The Journal of Gene Medicine. 21(1). e3066–e3066. 9 indexed citations
19.
Zhang, Li, Qifang Song, Ping Huang, et al.. (2017). Differential protein analysis of serum exosomes post-intravenous immunoglobulin therapy in patients with Kawasaki disease. Cardiology in the Young. 27(9). 1786–1796. 15 indexed citations
20.
Liu, Dong, et al.. (2017). Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis. Journal of International Medical Research. 45(2). 383–398. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026